📷 Image: Wikimedia Commons / James Abbott (1807-1896)
Business
Pharma Stocks Fall 4% Amid Trump Tariff Policy
✍️ livemint.com
🗓 24 Jul 2026, 02:08 PM
👁 2
Shares of Abbott India, Ajanta Pharma and Alembic fell up to 4% on the news of President Trump’s new tariff policy, sending Indian pharma stocks lower.
Indian pharmaceutical stocks took a hit on Friday as investors reacted to President Donald Trump’s announcement of a new tariff policy. Shares of key players Abbott India, Ajanta Pharma and Alembic fell as much as 4% in early trading.
The decline reflects market concerns that higher U.S. import duties could increase costs for Indian exporters and disrupt supply chains. Analysts noted that the pharma sector, already sensitive to global trade dynamics, may face additional pressure.
The drop was seen across the sector, with other listed companies also experiencing modest declines. Market watchers are monitoring how the policy will affect India’s position as a major supplier of generic drugs to the United States.
Investors are advised to keep a close eye on tariff developments and their potential impact on export‑oriented pharma firms.
The decline reflects market concerns that higher U.S. import duties could increase costs for Indian exporters and disrupt supply chains. Analysts noted that the pharma sector, already sensitive to global trade dynamics, may face additional pressure.
The drop was seen across the sector, with other listed companies also experiencing modest declines. Market watchers are monitoring how the policy will affect India’s position as a major supplier of generic drugs to the United States.
Investors are advised to keep a close eye on tariff developments and their potential impact on export‑oriented pharma firms.